Omar Ragy

Oxford Road
Manchester, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Multidisciplinary teams in lupus nephritis: where is the evidence for improved outcomes?

Multidisciplinary teams in lupus nephritis: where is the evidence for improved outcomes?

Journal: Clinical kidney journal

Published: May 18, 2026

ESKD from primary glomerulonephritis: Incidence and post KRT survival: A national cohort study in the UK.

ESKD from primary glomerulonephritis: Incidence and post KRT survival: A national cohort study in the UK.

Journal: PloS one

Published: September 16, 2025

Response to the Letter to the Editor Entitled "Re-examining the Causal Link Between Immunosuppression Delay and Kidney Outcomes in Autoimmune Membranous Nephropathy".

Response to the Letter to the Editor Entitled "Re-examining the Causal Link Between Immunosuppression Delay and Kidney Outcomes in Autoimmune Membranous Nephropathy".

Journal: Kidney international reports

Published: July 21, 2025

Kinetics of CD19+ B-cell depletion post-rituximab in membranous nephropathy.

Kinetics of CD19+ B-cell depletion post-rituximab in membranous nephropathy.

Journal: Clinical kidney journal

Published: May 12, 2025

Impact of Time-To-Treatment on Outcomes in Autoimmune Membranous Nephropathy.

Impact of Time-To-Treatment on Outcomes in Autoimmune Membranous Nephropathy.

Journal: Kidney international reports

Published: September 02, 2024

Use of rituximab and plasma exchange in treatment and prophylaxis of recurrent FSGS.

Use of rituximab and plasma exchange in treatment and prophylaxis of recurrent FSGS.

Journal: Clinical kidney journal

Published: July 04, 2024

PLA2R autoantibodies, a multifaceted biomarker in nephrotic syndrome and membranous nephropathy.

PLA2R autoantibodies, a multifaceted biomarker in nephrotic syndrome and membranous nephropathy.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: June 19, 2024

Time for a relook? An update on primary membranous nephropathy incidence in a large UK cohort.

Time for a relook? An update on primary membranous nephropathy incidence in a large UK cohort.

Journal: Clinical kidney journal

Published: December 04, 2023

Longitudinal Analysis of Prophylactic Anticoagulation in Primary Nephrotic Syndrome: Low Incidence of Thromboembolic Complications.

Longitudinal Analysis of Prophylactic Anticoagulation in Primary Nephrotic Syndrome: Low Incidence of Thromboembolic Complications.

Journal: Glomerular diseases

Published: June 05, 2023

Thromboembolism in nephrotic syndrome: controversies and uncertainties.

Thromboembolism in nephrotic syndrome: controversies and uncertainties.

Journal: Research and practice in thrombosis and haemostasis

Published: May 26, 2023

PLA2R Antibody Does Not Outperform Conventional Clinical Markers in Predicting Outcomes in Membranous Nephropathy.

PLA2R Antibody Does Not Outperform Conventional Clinical Markers in Predicting Outcomes in Membranous Nephropathy.

Journal: Kidney international reports

Published: January 16, 2023

Long-Term Safety, Clinical and Immunological Outcomes in Primary Membranous Nephropathy with Severe Renal Impairment Treated with Cyclophosphamide and Steroid-Based Regimen.

Long-Term Safety, Clinical and Immunological Outcomes in Primary Membranous Nephropathy with Severe Renal Impairment Treated with Cyclophosphamide and Steroid-Based Regimen.

Journal: Glomerular diseases

Published: April 01, 2022

Showing 1-12 of 13

Last Updated: 09/26/2026